Mobile Drug Testing Abo, NM
We Come To You On-Site!
Land, Air or Sea
24 Hours A Day, 7 Days A Week
Local Mobile Drug Testing and Mobile Alcohol Testing services in Abo, NM and the surrounding areas is provided at your business or other specified locations such as a Construction Site, Warehouse, Port, Office Building, Accident Scene or Hospital. Mobile Drug Testing in Abo, NM is available for DOT and NON-DOT Testing. Both laboratory analysis and instant result testing is offered.
How To Schedule A Mobile Drug Testing Service in Abo, NM
To schedule any type of Mobile Drug or Alcohol Test in Abo, NM, call our local scheduling department at (800) 221-4291. Information we will need includes, number of employees to be tested, type of test, preferred date and time and if the employees are DOT or NON-DOT regulated.
Mobile Drug Testing in Abo, NM
Our laboratories are SAMHSA certified and all test results are verified by our in-house licensed physicians who serve as Medical Review Officers (MRO).
Mobile drug testing is utilized in most cases by companies needing multiple employee drug tests performed on-site which will eliminate the need for employees to leave the worksite and go to a testing center; this prevents “down time”.
Mobile drug testing is also available when an employer wishes to conduct a “sweep” due to reasonable suspicion of drug use in the workplace.
Mobile drug testing services are also utilized for post-accident situations for DOT and NON-DOT drug and alcohol testing requirements.
Mobile Drug Testing for Abo, NM Employers
Mobile drug testing is used by many businesses including:
- Construction Sites
- Motor Pool Facilities
- Car Dealerships
- Trucking/Transportation Companies
- Sports Venues
- Oil & Gas Drilling Sites
Mobile DOT Drug and Alcohol Testing Services in Abo, NM
We also specialize in providing Mobile/On-site Drug Testing Services for all DOT Modes including Trucking Industry (FMCSA), Maritime Industry (USCG), Aviation Industry (FAA), Public Transportation (FTA), Railroad Industry (FRA) and Pipeline Industry (PHMSA) in accordance with Part 40 of the US Department of Transportation Compliance Regulations. Additional DOT Services include Consortium Enrollment, MVR reports, Supervisor Training and Policy Manual Development. In addition, we offer a complete DOT Compliance Program for single operators and small trucking companies.
Additional DOT Services:
- Consortium Enrollment
- DOT Physicals
- Supervisor Training
- Employer Drug Policy Development
- MVR Reports
- Employee Training
- Background Checks
- FMCSA Clearinghouse Verification/Search
The Opioid Overdose Crisis
Every day, more than 130 people in the United States die after overdosing on opioids. The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.
- Roughly 21 to 29 percent of patients prescribed opioids for chronic pain misuse them.
- Between 8 and 12 percent develop an opioid use disorder.
- An estimated 4 to 6 percent who misuse prescription opioids transition to heroin.
- About 80 percent of people who use heroin first misused prescription opioids.
- Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.
- The Midwestern region saw opioid overdoses increase 70 percent from July 2016 through September 2017.
- Opioid overdoses in large cities increase by 54 percent in 16 states.
In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and healthcare providers began to prescribe them at greater rates. This subsequently led to widespread diversion and misuse of these medications before it became clear that these medications could indeed be highly addictive.3,4 Opioid overdose rates began to increase. In 2017, more than 47,000 Americans died as a result of an opioid overdose, including prescription opioids, heroin, and illicitly manufactured fentanyl, a powerful synthetic opioid.1That same year, an estimated 1.7 million people in the United States suffered from substance use disorders related to prescription opioid pain relievers, and 652,000 suffered from a heroin use disorder (not mutually exclusive)
Drug Testing Locations in Abo, NM
In addition to providing Mobile/On-Site Drug Testing, Accredited Drug Testing has drug testing locations in Abo, NM and the surrounding areas. Many of our drug testing centers open early and have evening hours to accommodate a person's work schedule. Our drug testing locations in Abo, NM have certified and trained drug testing specialists ready to serve your testing needs in a friendly, knowledgeable and confidential manner.
Drug testing purposes for employers include pre-employment, random selection, post-accident and reasonable suspicion. Testing purposes for individuals can include court ordered, probation, child custody or for any other personal reason.
Accredited Drug Testing is a nationwide drug testing company with testing centers in Abo, NM specializing in Drug, Alcohol, DNA testing, DOT Physicals and Background Checks.
With over 20,000 testing centers throughout the United States, Accredited Drug Testing has testing centers in all States and in most cities and towns.
Certified Mobile Drug Testing Abo, NM
All Accredited Drug Testing specialists are certified and qualified for urine, hair and saliva drug collections and breath alcohol screenings for DOT and NON-DOT Drug and Alcohol Testing.
Which Drug Testing Panel Is Right For You?
Drug test screening groups are commonly referred to as a drug testing panel. The most common panels used are a 5 panel, 10 panel and 12 panel drug tests, (panels specify how many drugs will be screened) however customized screening can be analyzed for drugs such as opiates, bath salts, synthetic cannabinoids and a wide range of prescription drugs.
What Is A Drug Test?
A drug test is a technical analysis of a biological specimen, for example urine, hair, blood, breath, sweat, and/or oral fluid/saliva to determine the presence or absence of specified parent drugs or their metabolites. Major applications of drug testing include detection of the presence of performance enhancing steroids in sport, employers and parole/probation officers screening for drugs prohibited by law (such as cannabis, cocaine, methamphetamine, and heroin) and police officers testing for the presence and concentration of alcohol (ethanol) in the blood commonly referred to as BAC (blood alcohol content). BAC tests are typically administered via a breathalyzer while urinalysis is used for the vast majority of drug testing in sports and the workplace. Numerous other methods with varying degrees of accuracy, sensitivity (detection threshold/cutoff), and detection periods exist. A drug test may also refer to a test that provides quantitative chemical analysis of an illegal drug, typically intended to help with responsible drug use.
More Information About Mobile Drug Testing in Abo, NM
Mobile Drug Testing can also provide instant drug tests, where the result is available on-site. However, if an instant test has a non-negative result the specimen will be sent to a certified laboratory for confirmation testing.
Mobile drug testing is convenient and a cost-effective method when a company has multiple employees needing a drug or alcohol test.
When providing mobile drug testing for DOT employees, Accredited Drug Testing can provide all required documentation including the Federal Chain of Custody Forms.
Mobile Drug Testing Costs/Fees in Abo, NM
The fees for mobile drug testing can vary depending on the number of employees being tested, on-site location address and the time in which the on-site testing is needed. Call for more information or to schedule your Mobile/On-Site Drug Testing service in Abo, NM.
"When You Need a Test, Choose the Best"
Accredited Drug Testing Inc
Local Area Info: ABO (gene)
Histo-blood group ABO system transferase is an enzyme with glycosyltransferase activity, which is encoded by the ABO gene in humans. It is ubiquitously expressed in many tissues and cell types. ABO determines the ABO blood group of an individual by modifying the oligosaccharides on cell surface glycoproteins. Variations in the sequence of the protein between individuals determine the type of modification and the blood group. The ABO gene also contains one of 27 SNPs associated with increased risk of coronary artery disease.
The ABO gene resides on chromosome 9 at the band 9q34.2 and contains 7 exons. The ABO locus encodes three alleles. The A allele produces ?-1,3-N-acetylgalactosamine transferase (A-transferase), which catalyzes the transfer of GalNAc residues from the UDP-GalNAc donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into A antigen in A and AB individuals. The B allele encodes ?-1,3-galactosyl transferase (B-transferase), which catalyzes the transfer of Gal residues from the UDP-Gal donor nucleotide to the Gal residues of the acceptor H antigen, converting the H antigen into B antigen in B and AB individuals. Remarkably, the difference between the A and B glycosyltransferase enzymes is only four amino acids. The O allele lacks both enzymatic activities because of the frame shift caused by a deletion of guanine-258 in the gene which corresponds to a region near the N-terminus of the protein.This results in a frameshift and translation of an almost entirely different protein. This mutation results in a protein unable to modify oligosaccharides which end in fucose linked to galactose. Thus no A or B antigen is found in O individuals. This sugar combination is termed the H antigen. These antigens play an important role in the match of blood transfusion and organ transplantation. Other minor alleles have been found for this gene.
In human cells, the ABO alleles and their encoded glycosyltransferases have been described in several oncologic conditions. Using anti-GTA/GTB monoclonal antibodies, it was demonstrated that a loss of these enzymes was correlated to malignant bladder and oral epithelia. Furthermore, the expression of ABO blood group antigens in normal human tissues is dependent the type of differentiation of the epithelium. In most human carcinomas, including oral carcinoma, a significant event as part of the underlying mechanism is decreased expression of the A and B antigens. Several studies have observed that a relative down-regulation of GTA and GTB occurs in oral carcinomas in association with tumor development. More recently, a genome wide association study (GWAS) has identified variants in the ABO locus associated with susceptibility to pancreatic cancer.